CureCircleCureCircle
ConditionsValue your dataEvidenceGuidesFor research labsSign inShare your story
Conditions/Brain and nerves

Macular degeneration

What research knows about macular degeneration comes from people who live with it. Here is how many do, what records they usually have, and what sharing yours is worth.

Living with it

196 million

People with age-related macular degeneration worldwide, projected for 2020

source

New diagnoses

1.59 ... per 100 person-years

Pooled annual incidence of early age-related macular degeneration

source

How rare

Common

about 250 in 10,000 people

sourcesourcesource

What patients usually have

The records behind macular degeneration

  • Intravitreal anti-VEGF injection treatment

    Medication history

    repeated injections (regimen not stated)

    guideline
  • Fundus fluorescein angiography (FFA)

    Scan reports

    at diagnosis, if OCT does not exclude neovascular disease

    guideline
  • Optical coherence tomography (OCT) for suspected wet AMD

    Scan reports

    at diagnosis

    guideline
  • Ongoing OCT monitoring of both eyes in wet AMD

    Scan images

    ongoing (interval not stated in the guideline)

    guideline

What sharing it is worth

$71

per licence for a complete story and one year of these records, $71 to $837

Value your own data
  • Your health story$23how
  • Medication historyx1$2.33how
  • Scan reportsx2$4.86how
  • Scan imagesx1no price yethow
  • Richness premium (3 kinds of data linked)x2.33how

A benchmark from published prices, not a promise: contributors earn a share each time a licence includes their data. How the benchmark works · What health data sells for

Share your story about macular degenerationAll conditions
CureCircleCureCircle

Share your health. Help find cures. Get paid. Health data for research, owned by the people who share it.

Product

  • Conditions
  • Value your data
  • Evidence
  • Guides
  • For research labs
  • Sign in

Legal

  • Privacy Policy
  • Terms of Service
  • Support
© 2026 CureCircle. All rights reserved.

Operated by O-mega Enterprise, Inc